fdg tumor imaging pet clip clip number radiology reason esophageal restaging final report radiopharmeceutical data mci fdg indication year old man with esophageal cancer radiation chemotherapy restaging methods approximately hour intravenous administration fluorodeoxyglucose fdg noncontrast images were obtained attenuation correction fusion with emission pet images the noncontrast images used diagnose disease independently the pet images series overlapping emission pet images was then obtained the fasting blood glucose level measured glucometer injection fdg was the area imaged spanned the region the base the skull the upper part the thighs computed tomography images were registered fused with emission pet images assist with the anatomic localization tracer uptake the determination the site tracer uptake seen pet data can important implications regarding the significance that uptake comparison pet interpretation there small polyp the left sphenoid sinus the fdg avid junction gastric cardia mass seen prior scan decreased size fdg avid this scan there persistent thickening the gastric wall which non fdg avid the fdg avid porta hepatis lymph node adjacent lymph node prior scan markedly decreased size with ill defined margins fdg avid this scan there non fdg avid nodule the porta hepatis jejunostomy tube place with increased fdg uptake the skin insertion site there small cyst the right femoral head there degenerative changes the lower lumbar spine impression interval resolution the fdg avidity the mass junction gastric cardia interval resolution the fdg avidity porta hepatis lymph node adjacent lymph node compared prior scan evidence fdg avid disease activity increased fdg uptake jejunostomy insertion site likely secondary infectious inflammatory changes correlate clinically name name last name namepattern approved mon date mailed radline telephone fax radiology consult service hear preliminary results prior transcription call the radiology listen line telephone fax 